A comparative study of the quality control efficacy of multiple error-introduction methods for patient-based real-time quality control

针对基于患者的实时质量控制,对多种引入误差的方法进行质量控制效果的比较研究

阅读:1

Abstract

OBJECTIVE: This study aims to compare the quality control efficacy of multiple error-introduction methods for patient-based real-time quality control. METHOD: A total of 25 routine testing items covering clinical biochemistry, immunology, and hematology domains were included, using patient test data collected from January 2024 to December 2024 at the Xi'an Area Medical Laboratory Center. Exponentially Weighted Moving Average (EWMA) PBRTQC models were constructed using the AI-PBRTQC intelligent platform, with three weighting coefficients (λ = 0.02, 0.03, 0.05) evaluated for each item. Three error introduction approaches were compared: (1) real-world quality risk event validation, (2) manual experimental error creation, and (3) intelligent platform simulated systematic error addition. Model performance was assessed using four core metrics: error detection rate (Ped), false positive rate (FPR), false negative rate (FNR), and average number of patient samples before error detection (ANPed). RESULT: Real-world quality risk event validation for the total thyroxine (TT4) item demonstrated 100% concordance between PBRTQC alerts and IQC results during calibration events, confirming its value as the reference standard for model validation. The intelligent platform simulation method successfully identified optimal λ parameters for all 25 items, with λ = 0.05 achieving the best balance of high Ped (>90%) and low FPR (<5%) for 10 items including ALP, Urea, TT3, TT4, FT3, FT4, WBC, RBC, MCH, MCHC, while the remaining 15 items showed optimal performance at λ = 0.02 or 0.03. In contrast, the manual error creation method yielded valid parameters for vitamin B12 (VitB12, λ = 0.05, Ped = 100%, FPR = 5.27%) but failed to detect errors for TT3, TT4, and free thyroxine (FT4) across all tested λ values, suggesting limited generalizability. CONCLUSION: The joint application of the intelligent platform simulation error method and the real-world event method can significantly improve the screening efficiency of the PBRTQC model; however, the human-made error method requires further optimization and validation. The study provides a parameter-setting basis and a validation method reference for clinical laboratories to independently construct PBRTQC models, promoting the application of PBRTQC in practical scenarios.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。